Viewing data from:

PRAVASTATIN SODIUM

ANDA

PRAVASTATIN SODIUM | A209869 | BIOCON PHARMA INC

4 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 8 NDCs

Highest NADAC/Unit

$0.1496

per ea

Lowest NADAC/Unit

$0.0594

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
70377004812PRAVASTATIN SODIUM 80 MG TAB	$0.1496	EA	Generic	—	2026-06-17
70377004813PRAVASTATIN SODIUM 80 MG TAB	$0.1496	EA	Generic	—	2026-06-17
70377004712PRAVASTATIN SODIUM 40 MG TAB	$0.0846	EA	Generic	—	2026-06-17
70377004714PRAVASTATIN SODIUM 40 MG TAB	$0.0846	EA	Generic	—	2026-06-17
70377004612PRAVASTATIN SODIUM 20 MG TAB	$0.0622	EA	Generic	—	2026-06-17
70377004614PRAVASTATIN SODIUM 20 MG TAB	$0.0622	EA	Generic	—	2026-06-17
70377004512PRAVASTATIN SODIUM 10 MG TAB	$0.0594	EA	Generic	—	2026-06-17
70377004514PRAVASTATIN SODIUM 10 MG TAB	$0.0594	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 1 NDC (1 FSS)

Lowest Price

$81.31

Highest Price

$81.31

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
72162-1953-00PRAVASTATIN NA 40MG TAB	$81.31	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain5 active DMFs10 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVPRAVASTATIN SODIUM

DMF 147292000

BIOCON LTDPRAVASTATIN SODIUM USP

DMF 160482002

APOTEX PHARMACHEM INCPRAVASTATIN SODIUM

DMF 170232003

BIOCON LTDPRAVASTATIN SODIUM

DMF 174472004

CONCORD BIOTECH LTDPRAVASTATIN SODIUM USP

DMF 207272007

DAIICHI SANKYO CO LTDInactivePRAVASTATIN SODIUM DRUG SUBSTANCE

DMF 75681988

CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDInactivePRAVASTATIN SODIUM USP

DMF 142351999

LEK PHARMACEUTICALS DDInactivePRAVASTATIN SODIUM

DMF 159222002

RANBAXY LABORATORIES LTDInactivePRAVASTATIN SODIUM

DMF 160312002

LEK PHARMACEUTICALS DDInactivePRAVASTATIN SODIUM

DMF 162042002

ZHEJIANG HISUN PHARMACEUTICAL CO LTDInactivePRAVASTATIN SODIUM USP

DMF 163092002

KYOWA HAKKO KOGYO CO LTDInactivePRAVASTATIN SODIUM

DMF 169752003

GUANGDONG NEW NORTH RIVER PHARMACEUTICAL CO LTDInactivePRAVASTATIN SODIUM

DMF 185802005

ZHEJIANG HISUN PHARMACEUTICAL CO LTDInactivePRAVASTATIN SODIUM (AMORPHOUS, NON-STERILE ACTIVE PHARMACEUTICAL INGREDIENT)

DMF 187092005

ZHEJIANG HISUN PHARMACEUTICAL CO LTDInactivePRAVASTATIN SODIUM USP (PROCESS II)

DMF 276152013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 16, 2018	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (4)

Sort:

#001 — 10MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Apr 13, 2018

No patent or exclusivity listings for this strength.

#002 — 20MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 13, 2018

#003 — 40MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 13, 2018

#004 — 80MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 13, 2018